Clinical calculators dictate life-or-death medical decisions every day, but doctors have had no objective way to know which algorithms are actually safe to trust.
A new algorithm spots rare growth disorders years before traditional clinical methods, shifting the focus of pediatric screening from reactive tracking to active prediction.